Targeted Drug May Lower Odds for Breast Cancer's Return in Some Patients

A new clinical trial shows adding a targeted breast cancer drug to hormonal therapy reduced the risk of cancer returning by 25% for women with early-stage disease.

from WebMD Health https://ift.tt/1IZXoql